Literature DB >> 10333956

Emerging epidemic of type 2 diabetes in youth.

A L Rosenbloom1, J R Joe, R S Young, W E Winter.   

Abstract

This review considers the epidemiologic evidence of an increasing incidence of type 2 diabetes in youth, the classification and diagnostic issues related to diabetes in young populations, pathophysiologic mechanisms relevant to the increasing incidence, the role of genetics and environment, and the community challenge for prevention and treatment. Type 2 diabetes in youth has been recognized to be frequent in populations of native North Americans and to comprise some 30 percent of new cases of diabetes in the 2nd decade of life, largely accounted for by minority populations and associated with obesity. Among Japanese schoolchildren, type 2 diabetes is seven times more common than type 1, and its incidence has increased more than 30-fold over the past 20 years, concomitant with changing food patterns and increasing obesity rates. The forms of diabetes seen in children and youth include typical type 1, occurring in all races; type 2, seen predominantly in minority youth; atypical diabetes, seen as an autosomal dominantly transmitted disorder in African-American populations; and maturity-onset diabetes of the young (MODY), seen rarely and only in Caucasians. Of the nonautoimmune forms of diabetes seen in youth, only type 2 diabetes is increasing in incidence. Proper classification requires consideration of onset (acute/severe versus insidious), ethnicity, family history, presence of obesity, and if necessary, studies of diabetes related autoimmunity. Insulin resistance predicts the development of diabetes in Pima Indians, in offspring of parents with type 2 diabetes, and in other high-risk populations. African-American children and youth have greater insulin responses during glucose tolerance testing and during hyperglycemic clamp study than do whites. There is also evidence of altered beta-cell function preceding the development of hyperglycemia. Of particular interest is the evidence that abnormal fetal and infantile nutrition is associated with the development of type 2 diabetes in adulthood. The thrifty phenotype hypothesis states that poor nutrition in fetal and infant life is detrimental to the development and function of the beta-cells and insulin sensitive tissues, leading to insulin resistance under the stress of obesity. The thrifty genotype hypothesis proposes that defective insulin action in utero results in decreased fetal growth as a conservation mechanism, but at the cost of obesity-induced diabetes in later childhood or adulthood. The vast majority of type 2 diabetes in adults is polygenic and associated with obesity. Monogenic forms (MODY, maternally transmitted mitochondrial mutations) are rare, but are more likely to appear in childhood. Linkage studies of the common polygenic type 2 diabetes have emphasized the heterogeneity of the disorder. The prevention and treatment of type 2 diabetes in children and youth is a daunting challenge because of the enormous behavioral influence, difficulty in reversing obesity, and typical nonadherence in this age-group. The emerging epidemic of type 2 diabetes in the pediatric population, especially among minorities whose proportion in the U.S. population is increasing, presents a serious public health problem. The full effect of this epidemic will be felt as these children become adults and develop the long-term complications of diabetes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10333956     DOI: 10.2337/diacare.22.2.345

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  162 in total

1.  Policy statements adopted by the Governing Council of the American Public Health Association, November 15, 2000.

Authors: 
Journal:  Am J Public Health       Date:  2001-03       Impact factor: 9.308

Review 2.  Type 2 diabetes in children and youth.

Authors:  Francine Ratner Kaufman
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

3.  Type 2 diabetes in youth: are there racial differences in β-cell responsiveness relative to insulin sensitivity?

Authors:  Fida Bacha; Neslihan Gungor; Sojung Lee; Silva A Arslanian
Journal:  Pediatr Diabetes       Date:  2011-09-20       Impact factor: 4.866

Review 4.  Health services research for children with disabilities.

Authors:  James M Perrin
Journal:  Milbank Q       Date:  2002       Impact factor: 4.911

Review 5.  The use of bolus insulin and advancing insulin therapy in type 2 diabetes.

Authors:  Diane M Karl
Journal:  Curr Diab Rep       Date:  2004-10       Impact factor: 4.810

Review 6.  Determining genetic risk factors for pediatric type 2 diabetes.

Authors:  Angharad R Morgan
Journal:  Curr Diab Rep       Date:  2012-02       Impact factor: 4.810

7.  Socio-behavioral predictors of self-reported oral health-related quality of life.

Authors:  Carl A Maida; Marvin Marcus; Vladimir W Spolsky; Yan Wang; Honghu Liu
Journal:  Qual Life Res       Date:  2012-04-13       Impact factor: 4.147

Review 8.  The impact of disadvantage on the development and progression of diabetic kidney disease.

Authors:  E J Weil; J M Curtis; R L Hanson; W C Knowler; R G Nelson
Journal:  Clin Nephrol       Date:  2010-11       Impact factor: 0.975

9.  Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning.

Authors:  Ram Weiss; Sylvie Dufour; Sara E Taksali; William V Tamborlane; Kitt F Petersen; Riccardo C Bonadonna; Linda Boselli; Gina Barbetta; Karin Allen; Francis Rife; Mary Savoye; James Dziura; Robert Sherwin; Gerald I Shulman; Sonia Caprio
Journal:  Lancet       Date:  2003-09-20       Impact factor: 79.321

10.  Aerobic exercise but not resistance exercise reduces intrahepatic lipid content and visceral fat and improves insulin sensitivity in obese adolescent girls: a randomized controlled trial.

Authors:  SoJung Lee; Anthony R Deldin; David White; YoonMyung Kim; Ingrid Libman; Michelle Rivera-Vega; Jennifer L Kuk; Sandra Sandoval; Chris Boesch; Silva Arslanian
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-09-17       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.